Today on DrugResearcher.com
 
Ventana reluctantly opens up to Roche in a bid to boost offer

Accelrys offers academics its scientific operating system for free

Evotec's metamorphosis erodes profit

AstraZeneca in 'serious trouble', say analysts

Giving lung cancer a Smac

 
   
Related Industry News
 
BioCryst clinical trials debacle highlights protocol perils

Pharmaceutical manufacturing: people on the move

NPIL to trim ex-Pfizer site

PharmEng opens new Canada plant

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Wednesday 14 November 2007 Forward to a colleague

Product Presentation

SequantZIC®-HILIC Separation of Polar and Hydrophilic Compounds

The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here

Access Full Stories



Ventana reluctantly opens up to Roche in a bid to boost offer
In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read


Accelrys offers academics its scientific operating system for free
Accelrys is offering its SciTregic scientific operating system to academics for free to enable them to create software applications and share them with both academic and commercial communities... Read


Evotec's metamorphosis erodes profit
Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter... Read


AstraZeneca in 'serious trouble', say analysts
An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read


Giving lung cancer a Smac
A small molecule version of a protein called Smac can turn the survival signal for a variety of tumour cells into a death signal and could be effective as a new class of drug, especially for lung cancer patients... Read


All News Headlines for:
November | October | September

Fully autoclavable and Universal tip fittingSponsored Link

CappAero pipettes - ultimate accuracy and intelligent design

The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here

Related Industry News



BioCryst clinical trials debacle highlights protocol perils
BioCryst's recent clinical trials debacle highlights the importance of the robust and realistic design of, and careful adherence to, a drug trial protocol... Read


Pharmaceutical manufacturing: people on the move
AstraZeneca, Cumberland Pharmaceuticals, Pieris, Theraptosis and InteKrin Therapeutics have all had people on the move in the world of pharmaceutical manufacturing... Read


NPIL to trim ex-Pfizer site
NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability... Read


PharmEng opens new Canada plant
Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business... Read


Weekly Comment

Pharma must 'reinvent' itself to survive

With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market. Read



SMI Anti-Arthritic ConferenceSponsored Link

7th Annual Anti-Arthritic Agents Conference

Examine the latest developments in the research of therapeutics for Arthritic and Inflammatory indications, and listen to case studies from the leading companies in the field. 19th & 20th November 2007, Hesperia Victoria Hotel, UK... Click Here
Previous Headlines



Applied Biosystems and BioTrove form HT genotyping alliance
Applied Biosystems and BioTrove have signed a licensing and collaboration agreement to commercialise an analysis platform for high-throughput (HT) genotyping applications... Read


Nanogen scraps microarray business in favour of PCR assays
Nanogen has decided to pull the plug on its microarray business after not finding any 'financially meaningful opportunities' for it, reducing staff by 20 per cent in the process... Read


New drug safety model unveiled as Merck shells out for Vioxx
A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments... Read


WHO talks on research strategy for developing world diseases stall
Talks between World Health Organization (WHO) member states and the drug industry over how to narrow the health gap between rich and poor countries have stalled... Read


BAC looks to enhance laboratory purification with new antibody toolkit
Bio Affinity Company (BAC) has launched a new antibody purification toolbox based on its successful industrial-scale technology to provide researchers with a simpler purification route... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation

DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com